在腹腔镜手术患者中治疗术后恶心和吐的德克斯梅托米丁和埃斯基他胺的组合:前性随机受控试验的研究方案
Ying Zhou1, Ziyi Shen1, Jinbiao Li1
1Department of Anesthesiology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, China.
Trials
|July 2, 2025
概括
这项研究研究了德克斯梅托米丁和胺的联合使用,以预防腹腔镜手术中的术后恶心和吐 (PONV). 新的阿片类药物节约策略旨在改善患者的康复和满意度.
科学领域:
- 麻醉学 麻醉学
- 术后恢复 术后恢复
- 药理学 药理学是指药理学的学科.
背景情况:
- 腹腔镜手术有好处,但手术后恶心和吐 (PONV) 仍然是一个显著的并发症.
- 通常用于疼痛的阿片类药物可以加剧PONV,需要使用阿片类药物节约方法.
- 德克斯梅德托米丁和埃斯基坦胺在治疗PONV和疼痛方面表现出个别的希望.
研究的目的:
- 为了评估腹镜外科手术中PONV预防的联合德克斯梅德托米丁和埃斯基坦胺麻醉策略的疗效和安全性.
- 评估这种组合在减少阿片类药物需求和改善术后恢复方面的潜力.
主要方法:
- 一个前性,随机的受控试验,比较组合治疗 (德克塞梅托米丁,乙胺,苏芬坦尼尔,普罗波) 与对照组 (苏芬坦尼尔,普罗波,雷米芬坦尼尔).
- 主要结局:术后48小时内PONV发生率.
- 二级结局:疼痛评分,救援药物使用,患者满意度和不良事件.
主要成果:
- 本部分应在研究结果可用后填写.
- 该研究旨在提供有关PONV发病率,疼痛管理和患者报告结果的数据.
- 将评估联合麻醉方案的安全性和可行性.
结论:
- 这项研究旨在确定用于PONV预防的配合德克斯梅托米丁和乙胺的安全性和可行性.
- 这些发现可能支持一种有效的阿片类药物降低麻醉策略,以加强腹腔镜手术后的恢复.
- 这项研究可以为在麻醉中更广泛的临床应用提供宝贵的见解.
相关概念视频
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
180
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
180
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
265
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
265
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
330
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
330
Parenteral Anesthetics: Overview
205
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
205
Stages of General Anesthesia
733
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
733
Depolarizing Blockers: Pharmocokinetics
389
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
389


